PIERANTONI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 98
AS - Asia 72
EU - Europa 32
Totale 202
Nazione #
US - Stati Uniti d'America 98
SG - Singapore 57
IT - Italia 19
CN - Cina 15
FR - Francia 4
DE - Germania 3
GB - Regno Unito 2
SE - Svezia 2
FI - Finlandia 1
IE - Irlanda 1
Totale 202
Città #
Singapore 47
Santa Clara 23
Boardman 14
New York 8
Fairfield 6
Padova 5
Calcinato 4
Cambridge 4
San Diego 3
Venice 3
Woodbridge 3
Ashburn 2
Bologna 2
Chandler 2
Islington 2
Milan 2
Beijing 1
Council Bluffs 1
Des Moines 1
Dublin 1
Lappeenranta 1
Lower Saxony 1
Medford 1
Ogden 1
Princeton 1
Seattle 1
Ulm 1
Totale 141
Nome #
Prognostic Stratification of Metastatic Prostate Cancer Patients Treated With Abiraterone and Enzalutamide Through an Integrated Analysis of Circulating Free microRNAs and Clinical Parameters 45
Prognostic role of systemic inflammation indexes in metastatic urothelial carcinoma treated with immunotherapy 17
Patient Reported Outcomes, Paternity, Relationship, and Fertility in Testicular Cancer Survivors: Results from a Prospective Observational Single Institution Trial 17
Nivolumab drug holiday in patients treated for metastatic renal cell carcinoma: A real-world, single-centre experience 15
Immune checkpoint inhibitors rechallenge in urological tumors: An extensive review of the literature 15
Advanced Non-Clear Cell Renal Cell Carcinoma Treatments and Survival: A Real-World Single-Centre Experience 14
Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations 14
Clinical relevance of molecular biomarkers in urothelial carcinomas treated with chemotherapy, immunotherapy or targeted-therapies 13
The prognostic Value of Thyroid Hormone Levels in Immunotherapy-Treated Patients With Metastatic Urothelial Carcinoma 13
Role of Bone Metastases in Patients Receiving Immunotherapy for Pre-Treated Urothelial Carcinoma: The Multicentre, Retrospective Meet-URO-1 Bone Study 12
Real-World Treatment with Nivolumab or Cabozantinib for Metastatic Renal Cell Carcinoma (mRCC) in the Veneto Region of Italy: Results of AMOUR Study 12
Comprehensive geriatric assessment is an independent prognostic factor in older patients with metastatic renal cell cancer treated with first-line Sunitinib or Pazopanib: a single center experience 12
Addition of Niraparib to Best Supportive Care as Maintenance Treatment in Patients with Advanced Urothelial Carcinoma Whose Disease Did Not Progress After First-line Platinum-based Chemotherapy: The Meet-URO12 Randomized Phase 2 Trial 10
Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a) 7
Totale 216
Categoria #
all - tutte 2.064
article - articoli 2.031
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.095


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/202229 11 1 0 0 1 8 1 0 0 2 1 4
2022/20233 2 0 0 0 0 1 0 0 0 0 0 0
2023/202458 0 1 1 2 15 11 0 6 3 0 5 14
2024/2025125 0 66 14 18 27 0 0 0 0 0 0 0
Totale 216